Dr. Nohria is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
111 Skyline View Rd
Franklin, NC 28734Phone+1 828-349-0247Fax+1 828-349-3517
Education & Training
Duke University HospitalResidency, Pediatrics, 1990 - 1993- Duke University HospitalResidency, Pediatrics, 1988 - 1988
School of Clinical Medicine, University of CambridgeClass of 1985
Certifications & Licensure
GA State Medical License 1998 - 2025
NC State Medical License 1994 - 2025
VA State Medical License 1995 - 2024
Publications & Presentations
PubMed
- 5 citationsAdjunctive use of ezogabine/retigabine with either traditional sodium channel blocking antiepileptic drugs (AEDs) or AEDs with other mechanisms of action: Evaluation o...Martin J. Brodie, Jacqueline A. French, Susan A. McDonald, Wen-Jene Lee, Bryan Adams
Epilepsy Research. 2014-07-01 - 7 citationsA novel design for a dose finding, safety, and drug interaction study of an antiepileptic drug (retigabine) in early clinical development.Rajesh Sachdeo, Arnaud Partiot, Victor Biton, William E. Rosenfeld, Virinder Nohria
International Journal of Clinical Pharmacology and Therapeutics. 2014-06-01 - 14 citationsSafety and tolerability of different titration rates of retigabine (ezogabine) in patients with partial-onset seizures.Victor Biton, Antonio Gil-Nagel, Martin J. Brodie, Sarah DeRossett, Virinder Nohria
Epilepsy Research. 2013-11-01
Press Mentions
- Saol Therapeutics Enhances Its IP Portfolio for Dichloroacetate (DCA; SL-1009) in Glioblastoma and Rare Pediatric CancersMarch 16th, 2023
Professional Memberships
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
